XTLB logo

XTL Biopharmaceuticals (XTLB) Retained Earnings

Annual Retained Earnings

-$158.25 M
-$1.78 M-1.14%

31 December 2023

XTLB Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$157.76 M
+$485.00 K+0.31%

31 March 2024

XTLB Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

XTLB Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.1%+0.1%
3 y3 years-1.7%-
5 y5 years-4.2%-

XTLB Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-2.0%at low-1.9%+0.3%
5 y5 years-4.2%at low-3.3%+0.3%
alltimeall time-128.3%at low-98.8%+0.3%

XTL Biopharmaceuticals Retained Earnings History

DateAnnualQuarterly
Mar 2024
-
-$157.76 M(-0.3%)
Dec 2023
-$158.25 M(+1.1%)
-$158.25 M(+0.2%)
Sept 2023
-
-$157.97 M(+0.1%)
June 2023
-
-$157.75 M(+0.2%)
Mar 2023
-
-$157.38 M(+0.6%)
Dec 2022
-$156.47 M(+0.9%)
-$156.47 M(+0.5%)
Sept 2022
-
-$155.72 M(+0.5%)
June 2022
-
-$154.90 M(-0.1%)
Dec 2021
-$155.13 M(-0.3%)
-$155.13 M(-0.8%)
June 2021
-
-$156.45 M(+0.5%)
Dec 2020
-$155.60 M(+1.9%)
-$155.60 M(+1.9%)
Dec 2019
-$152.70 M(+0.5%)
-$152.70 M(+0.5%)
Dec 2018
-$151.94 M(-2.4%)
-$151.94 M(-2.4%)
Dec 2017
-$155.65 M(+0.5%)
-$155.65 M(-0.0%)
Sept 2017
-
-$155.65 M(-1.0%)
June 2017
-
-$157.24 M(+1.5%)
Dec 2016
-$154.90 M(+1.6%)
-$154.90 M(+0.9%)
June 2016
-
-$153.46 M(+0.6%)
Dec 2015
-$152.49 M(+2.8%)
-$152.49 M(+1.6%)
Sept 2015
-
-$150.15 M(+0.3%)
June 2015
-
-$149.74 M(+1.0%)
Dec 2014
-$148.32 M(+1.5%)
-$148.32 M(+0.5%)
Sept 2014
-
-$147.59 M(+0.3%)
June 2014
-
-$147.13 M(+0.3%)
Mar 2014
-
-$146.63 M(+0.4%)
DateAnnualQuarterly
Dec 2013
-$146.07 M(+1.8%)
-$146.07 M(+0.9%)
Sept 2013
-
-$144.77 M(-0.1%)
June 2013
-
-$144.94 M(+0.5%)
Mar 2013
-
-$144.15 M(+0.4%)
Dec 2012
-$143.56 M(+2.6%)
-$143.56 M(-0.0%)
Sept 2012
-
-$143.60 M(-0.3%)
June 2012
-
-$144.02 M(+0.3%)
Mar 2012
-
-$143.61 M(+0.4%)
Sept 2011
-
-$143.00 M(+0.2%)
June 2011
-
-$142.68 M(+0.2%)
Mar 2011
-
-$142.42 M(+0.4%)
Sept 2010
-
-$141.86 M(+0.1%)
June 2010
-
-$141.72 M(+0.2%)
Mar 2010
-
-$141.45 M(+0.3%)
Sept 2009
-
-$140.99 M(-4.1%)
June 2008
-
-$146.98 M(+5.1%)
Dec 2007
-$139.86 M(+21.7%)
-$139.86 M(+7.9%)
June 2007
-
-$129.57 M(+12.7%)
Dec 2006
-$114.92 M(+15.2%)
-$114.92 M(+7.3%)
June 2006
-
-$107.08 M(+7.3%)
Dec 2005
-$99.79 M(+16.3%)
-$99.79 M(+10.0%)
June 2005
-
-$90.73 M(+5.8%)
Dec 2004
-$85.78 M(+23.8%)
-$85.78 M(+8.1%)
June 2004
-
-$79.37 M
Dec 2003
-$69.30 M
-

FAQ

  • What is XTL Biopharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals annual retained earnings year-on-year change?
  • What is XTL Biopharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals quarterly retained earnings year-on-year change?

What is XTL Biopharmaceuticals annual retained earnings?

The current annual retained earnings of XTLB is -$158.25 M

What is the all time high annual retained earnings for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high annual retained earnings is -$69.30 M

What is XTL Biopharmaceuticals annual retained earnings year-on-year change?

Over the past year, XTLB annual retained earnings has changed by -$1.78 M (-1.14%)

What is XTL Biopharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of XTLB is -$157.76 M

What is the all time high quarterly retained earnings for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high quarterly retained earnings is -$79.37 M

What is XTL Biopharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, XTLB quarterly retained earnings has changed by +$204.00 K (+0.13%)